# Injective Labs Inc.

Injective Labs Inc. is a Software Development based in Dublin, Ireland.

## Overview

- **Organization type:** Software Development
- **Headquarters:** Dublin, Ireland
- **Region:** North America
- **Address:** Dublin, Ireland
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** https://injective.com
- **LinkedIn:** https://www.linkedin.com/company/injective-labs

## Regulatory record

- **Reports private funds:** No

## About

Injective Labs was founded by Eric Chen and Albert Chon, who previously worked at leading blockchain projects. The firm's wealth origin is not publicly disclosed, but it has raised venture funding from investors including Pantera Capital, Binance Labs, and Mark Cuban. The company develops the Injective Protocol, a blockchain optimized for decentralized derivatives and spot trading. The firm's core product is the Injective chain, which uses Tendermint consensus and supports interoperability with Ethereum, Cosmos, and other blockchains via IBC bridges. Injective Labs earns revenue from transaction fees on the network and provides development tools for building DeFi applications. The protocol enables perpetual swaps, futures, and options trading without centralized order books. Injective Labs employs a team of blockchain engineers and cryptographers distributed across its four office locations. The company has not disclosed total assets under management or deployment figures, as it operates primarily as a technology development entity rather than an investment fund. In 2023, Injective Protocol launched its mainnet and has since processed over $1 billion in cumulative trading volume (per CoinDesk, 2023). The firm's structural differentiator is its focus on building a sovereign blockchain specifically for DeFi, rather than launching on existing platforms like Ethereum. This approach gives Injective Labs control over protocol parameters and fee structures, allowing customization for institutional-grade trading features.

## Sectors

- Blockchain & Crypto
- FinTech
- AI/ML

## Offices

- Hong Kong
- Singapore
- New York, United States

## Questions

### How does Injective Labs source its revenue?

The firm earns transaction fees from the Injective blockchain network. It also provides development and consulting services for projects building on the protocol.

### What investment stages does Injective Labs target?

Injective Labs does not operate as an investment fund. It focuses on protocol development and ecosystem growth through its own treasury and grant programs.

### Which sectors does Injective Labs focus on?

The firm's primary focus is blockchain infrastructure and decentralized finance (DeFi), including derivatives trading, cross-chain interoperability, and DeFi applications.

## Related profiles

- [Alliance](https://altss.com/profile/defi-alliance-llc)
- [Progressive Investment Management](https://altss.com/profile/progressive-investment-company)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/injective-labs-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology